MX2016014606A - Un nanocomplejo micelar. - Google Patents
Un nanocomplejo micelar.Info
- Publication number
- MX2016014606A MX2016014606A MX2016014606A MX2016014606A MX2016014606A MX 2016014606 A MX2016014606 A MX 2016014606A MX 2016014606 A MX2016014606 A MX 2016014606A MX 2016014606 A MX2016014606 A MX 2016014606A MX 2016014606 A MX2016014606 A MX 2016014606A
- Authority
- MX
- Mexico
- Prior art keywords
- micellar
- micelle
- micellar nanocomplex
- nanocomplex
- polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/3311—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group
- C08G65/3314—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic
- C08G65/3315—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic aromatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/3311—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group
- C08G65/3314—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic
- C08G65/3315—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic aromatic
- C08G65/3317—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic aromatic phenolic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/3311—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group
- C08G65/3318—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3324—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic
- C08G65/3326—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic aromatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3328—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/02—Starch; Degradation products thereof, e.g. dextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/02—Dextran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Abstract
La presente invención se refiere a nanocomplejos micelares y un método para formar los mismos. El nanocomplejo micelar comprende una micela y un agente encapsulado dentro de la micela, en donde la micela comprende un conjugado polímero-flavonoide, en donde el polímero es enlazado al anillo B del flavonoide. El nanocomplejo micelar puede tener aplicaciones útiles como un sistema de suministro de fármaco.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201402244S | 2014-05-09 | ||
PCT/SG2015/050104 WO2015171079A1 (en) | 2014-05-09 | 2015-05-08 | A micellar nanocomplex |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016014606A true MX2016014606A (es) | 2017-08-24 |
Family
ID=54392771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016014606A MX2016014606A (es) | 2014-05-09 | 2015-05-08 | Un nanocomplejo micelar. |
Country Status (18)
Country | Link |
---|---|
US (2) | US10052307B2 (es) |
EP (1) | EP3139915B1 (es) |
JP (1) | JP6307631B2 (es) |
KR (2) | KR102102093B1 (es) |
CN (1) | CN106659708B (es) |
AU (1) | AU2015256667C1 (es) |
BR (1) | BR112016026260A2 (es) |
CA (1) | CA2948460C (es) |
CU (1) | CU24520B1 (es) |
EA (1) | EA035820B1 (es) |
ES (1) | ES2847602T3 (es) |
IL (1) | IL248632B (es) |
MX (1) | MX2016014606A (es) |
SA (1) | SA516380256B1 (es) |
SG (1) | SG11201609333YA (es) |
UA (1) | UA118479C2 (es) |
WO (1) | WO2015171079A1 (es) |
ZA (1) | ZA201608424B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3041830B1 (en) * | 2013-09-03 | 2023-10-25 | Agency For Science, Technology And Research | Polymer-flavonoid conjugates and hydrogels for biomedical applications |
US10052307B2 (en) | 2014-05-09 | 2018-08-21 | Agency For Science, Technology And Research | Micellar nanocomplex |
US11241520B2 (en) | 2014-08-07 | 2022-02-08 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
US9655998B2 (en) | 2014-08-07 | 2017-05-23 | Cook Medical Technologies Llc | Encapsulated drug compositions and methods of use thereof |
US9180226B1 (en) | 2014-08-07 | 2015-11-10 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
CN106511362B (zh) * | 2015-09-15 | 2020-11-17 | 广东省人民医院 | 一种防治动脉粥样硬化的茶多酚组合物 |
WO2017204475A1 (ko) * | 2016-05-24 | 2017-11-30 | 한양대학교 산학협력단 | 항암제 함유 나노입자를 포함하는 뇌질환 치료를 위한 비강 투여용 약제학적 조성물 |
EP3251662A1 (en) * | 2016-06-07 | 2017-12-06 | Tolerogenics S.à.r.l. | Matrix-embedded tolerance-promotion adjuvants for subcutaneous immunotherapy |
US10993917B2 (en) * | 2016-12-30 | 2021-05-04 | Agency For Science, Technology And Research | Nanocomplex |
KR101810156B1 (ko) * | 2017-02-27 | 2017-12-19 | 인제대학교 산학협력단 | 폴리에틸렌 글리콜 및 플라보노이드 나노복합체를 유효성분으로 함유하는 안구 건조증 예방 또는 치료용 조성물 |
KR20200100028A (ko) * | 2017-07-20 | 2020-08-25 | 암리 에스에스씨아이 엘엘씨 | 에피갈로카테킨 갈레이트의 무정형 분산물 |
CN107501584A (zh) * | 2017-08-30 | 2017-12-22 | 天津工业大学 | 一种新型复合膜的制备方法 |
KR102158730B1 (ko) * | 2018-04-02 | 2020-09-22 | 주식회사 옵티팜 | 세포 피막화용 알지네이트 미세캡슐 및 이의 제조방법 |
TWI764186B (zh) | 2018-06-15 | 2022-05-11 | 漢達生技醫藥股份有限公司 | 激酶抑制劑之鹽類及其組合物 |
KR20200036774A (ko) * | 2018-09-28 | 2020-04-07 | 주식회사 삼양바이오팜 | 독소루비신을 유효성분으로 하는 조성물 및 그 제조 방법 |
JP2022510986A (ja) * | 2018-12-12 | 2022-01-28 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | ヒアルロン酸およびエピガロカテキン-3-o-没食子酸のコンジュゲートおよびナノ粒子ならびにその使用 |
CN109820815B (zh) * | 2019-02-15 | 2022-02-08 | 山东师范大学 | 一种具有pH响应的姜黄素胶束水凝胶及其制备方法 |
US11596643B2 (en) * | 2019-06-18 | 2023-03-07 | Sichuan Yingrui Pharmaceutical Technology Company | Pectin-adriamycin conjugate as well as preparation method and use thereof |
CN115461354A (zh) | 2020-02-14 | 2022-12-09 | 长庚医疗财团法人林口长庚纪念医院 | 用于分子缀合或改造的串联重复癌症靶向肽及其在癌症治疗诊断学中的用途 |
CN113368080B (zh) * | 2020-02-25 | 2023-11-17 | 香港中文大学 | 稳定的、生物粘附的、扩散限制性团聚体 |
WO2023043367A2 (en) * | 2021-09-15 | 2023-03-23 | Agency For Science, Technology And Research | Green tea-based nanocomplexes for eye disease |
WO2023076220A1 (en) * | 2021-10-25 | 2023-05-04 | Board Of Regents, The University Of Texas System | Conjugates having antifouling nanoparticles and methods of use |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000074662A2 (en) * | 1999-06-07 | 2000-12-14 | University Of Sheffield | Arthritis treatment |
WO2006116532A2 (en) * | 2005-04-28 | 2006-11-02 | University Of Massachusetts Lowell | Synthesis of oligo/poly(catechins) and methods of use |
EP1888651B1 (en) * | 2005-05-20 | 2014-07-30 | Agency for Science, Technology and Research | Aldehyde conjugated flavonoid preparations |
KR101576310B1 (ko) * | 2007-10-23 | 2015-12-09 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | 세포에 항암제를 전달하는 방법 |
SG10201501829YA (en) | 2010-03-11 | 2015-05-28 | Agency Science Tech & Res | Anti-cancer agent delivery vehicles capable of improved loading |
JP2012005413A (ja) * | 2010-06-24 | 2012-01-12 | Osamu Numata | 高分子ポリフェノールを含有する発酵茶抽出物の調製方法 |
US20140294724A1 (en) * | 2011-10-24 | 2014-10-02 | Intellect Neurosciences, Inc. | Compositions and methods for treatment of proteinopathies |
EP3041830B1 (en) | 2013-09-03 | 2023-10-25 | Agency For Science, Technology And Research | Polymer-flavonoid conjugates and hydrogels for biomedical applications |
CA2902811A1 (en) * | 2014-01-24 | 2015-07-30 | Linde Process Plants, Inc. | Methods for separating hydrocarbon gases |
US10052307B2 (en) | 2014-05-09 | 2018-08-21 | Agency For Science, Technology And Research | Micellar nanocomplex |
-
2015
- 2015-05-08 US US15/309,675 patent/US10052307B2/en active Active
- 2015-05-08 UA UAA201612494A patent/UA118479C2/uk unknown
- 2015-05-08 EP EP15789009.6A patent/EP3139915B1/en active Active
- 2015-05-08 BR BR112016026260-3A patent/BR112016026260A2/pt not_active Application Discontinuation
- 2015-05-08 WO PCT/SG2015/050104 patent/WO2015171079A1/en active Application Filing
- 2015-05-08 CN CN201580035396.6A patent/CN106659708B/zh active Active
- 2015-05-08 SG SG11201609333YA patent/SG11201609333YA/en unknown
- 2015-05-08 MX MX2016014606A patent/MX2016014606A/es unknown
- 2015-05-08 KR KR1020197022703A patent/KR102102093B1/ko active IP Right Grant
- 2015-05-08 KR KR1020167034578A patent/KR20170007780A/ko active Search and Examination
- 2015-05-08 CA CA2948460A patent/CA2948460C/en active Active
- 2015-05-08 JP JP2016566958A patent/JP6307631B2/ja active Active
- 2015-05-08 AU AU2015256667A patent/AU2015256667C1/en not_active Ceased
- 2015-05-08 ES ES15789009T patent/ES2847602T3/es active Active
- 2015-05-08 CU CU2016000164A patent/CU24520B1/es unknown
- 2015-05-08 EA EA201692213A patent/EA035820B1/ru not_active IP Right Cessation
-
2016
- 2016-10-31 IL IL248632A patent/IL248632B/en active IP Right Grant
- 2016-11-08 SA SA516380256A patent/SA516380256B1/ar unknown
- 2016-12-07 ZA ZA2016/08424A patent/ZA201608424B/en unknown
-
2018
- 2018-07-18 US US16/039,098 patent/US10463646B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2017518280A (ja) | 2017-07-06 |
CA2948460A1 (en) | 2015-11-12 |
IL248632B (en) | 2021-03-25 |
SG11201609333YA (en) | 2016-12-29 |
CA2948460C (en) | 2020-10-13 |
BR112016026260A2 (pt) | 2021-08-03 |
AU2015256667B2 (en) | 2018-04-19 |
CN106659708B (zh) | 2022-05-10 |
UA118479C2 (uk) | 2019-01-25 |
AU2015256667C1 (en) | 2018-07-05 |
EP3139915A4 (en) | 2017-12-20 |
CU20160164A7 (es) | 2017-05-10 |
EP3139915B1 (en) | 2020-11-04 |
US10052307B2 (en) | 2018-08-21 |
US20190008830A1 (en) | 2019-01-10 |
KR102102093B1 (ko) | 2020-04-17 |
KR20170007780A (ko) | 2017-01-20 |
EA201692213A1 (ru) | 2017-06-30 |
JP6307631B2 (ja) | 2018-04-04 |
SA516380256B1 (ar) | 2021-02-25 |
ZA201608424B (en) | 2019-12-18 |
ES2847602T3 (es) | 2021-08-03 |
CN106659708A (zh) | 2017-05-10 |
KR20190095510A (ko) | 2019-08-14 |
AU2015256667A1 (en) | 2016-11-17 |
US20170258926A1 (en) | 2017-09-14 |
IL248632A0 (en) | 2017-01-31 |
WO2015171079A1 (en) | 2015-11-12 |
US10463646B2 (en) | 2019-11-05 |
EA035820B1 (ru) | 2020-08-17 |
CU24520B1 (es) | 2021-06-08 |
EP3139915A1 (en) | 2017-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016014606A (es) | Un nanocomplejo micelar. | |
PH12018500950A1 (en) | Subcutaneous formulations of anti-cd38 antibodies and their uses | |
PH12018500947B1 (en) | Crystal form, preparation method and intermediate of dihydropyrido ring compound | |
MX2019003735A (es) | Formulaciones diluibles de cannabinoides y procesos para su preparacion. | |
IL262581A (en) | Production methods, preparations and medical applications of drugs containing cannabis for oral administration | |
TR201908550T4 (tr) | Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi. | |
AU2018335389A1 (en) | Nanofiber structures and methods of use thereof | |
TN2015000411A1 (en) | Ceftolozane antibiotic compositions | |
BR112017018620A2 (pt) | método de administração de tradipitanto, e, tradipitanto. | |
MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
NZ742805A (en) | Anti-cd22 antibody-maytansine conjugates and methods of use thereof | |
MX2019005855A (es) | Formulaciones que se pueden pulverizar. | |
MY197524A (en) | System of multiple bags and method for the preparation of hemocomponents | |
MX369072B (es) | Producto para el cuidado bucal y métodos para uso y fabricación de este. | |
MX2018005085A (es) | Nanoparticulas terapeuticas que comprenden un agente terapeutico y metodos de fabricacion y uso de las mismas. | |
MX368268B (es) | Formulacion de atazanavir y cobicistat para el tratamiento del virus de inmunodeficiencia humana (vih). | |
MY192342A (en) | Thickening and/or shear-thinning polyester | |
EP3400107A4 (en) | PUMP SYSTEMS AND ENGINES AND METHODS OF MAKING THE SAME | |
RS62793B1 (sr) | Heterobasidion annosum ekstrakt protiv kancera, kompozicije i njihova primena | |
AU2016250265A8 (en) | (S)-2'-vinyl-abscisic acid derivatives | |
GR20150100035A (el) | Φαρμακευτικο σκευασμα περιεχον απρεπιταντη και μεθοδος παρασκευης αυτου | |
AU2017268453A8 (en) | Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections | |
WO2017059318A3 (en) | Scaphopetalone analogs and their uses | |
IT201700039385U1 (it) | Inserto per il confezionamento di clismi pre-riempiti, clismi pre-riempiti e procedimento per la realizzazione di clismi pre-riempiti | |
UA100710U (xx) | Застосування капсул "фітовенол" як гепатопротекторного засобу |